Archaeosome Vaccine Adjuvants for Cross-Priming CD8+ T-Cell Immunity

Vaccine Adjuvants and Delivery Systems

Volumn , Issue , 2006, Pages 263-294

  Krishnan, Lakshmi ^a   Sprott, G Dennis ^a  

^a NATIONAL RESEARCH COUNCIL CANADA   (Canada)

Author keywords

Archaeal lipid structures; Archaeosome vaccine adjuvants; Archaeosomes and strong CD8+ T cell immunity

Indexed keywords

EID: 41549168493     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470134931.ch12     Document Type: Chapter

References (89)

1. Yu, Z. & Restifo, N.P. Cancer vaccines: progress reveals new complexities. J Clin Invest 2002, 110(3), 289-294.
2. Pashine, A., Valiante, N.M. & Ulmer, J.B. Targeting the innate immune response with improved vaccine adjuvants. Nat Med 2005, 11(4 Suppl), S63-S68.
3. Kovacsovics-Bankowski, M. & Rock, K.L. A phagosome-to-cytosol pathway for exogenous antigens presented on MHC class I molecules. Science 1995, 267(5195), 243-246.
4. Singh, M. & O'Hagan, D.T. Recent advances in vaccine adjuvants. Pharm Res 2002, 19(6), 715-728.
5. Lingnau, K., Egyed, A., Schellack, C., Mattner, F., Buschle, M. & Schmidt, W. Poly-L-arginine synergizes with oligodeoxynucleotides containing CpG-motifs (CpG-ODN) for enhanced and prolonged immune responses and prevents the CpG-ODN-induced systemic release of pro-infl ammatory cytokines. Vaccine 2002, 20(29-30), 3498-3508.
6. Richards, R.L., Rao, M., Wassef, N.M., Glenn, G.M., Rothwell, S.W. & Alving, C.R. Liposomes containing lipid A serve as an adjuvant for induction of antibody and cytotoxic T-cell responses against RTS,S malaria antigen. Infect Immun 1998, 66(6), 2859-2865.
7. Medina, E. & Guzman, C.A. Use of live bacterial vaccine vectors for antigen delivery: potential and limitations. Vaccine 2001, 19(13-14), 1573-1580.
8. Murali-Krishna, K., Altman, J.D., Suresh, M., Sourdive, D.J., Zajac, A.J., Miller, J.D. et al. Counting antigen-specifi c CD8 T cells: a reevaluation of bystander activation during viral infection. Immunity 1998, 8(2), 177-187.
9. Moron, V.G., Rueda, P., Sedlik, C. & Leclerc, C. In vivo, dendritic cells can crosspresent virus-like particles using an endosome-to-cytosol pathway. J Immunol 2003, 171(5), 2242-2250.
10. Kaisho, T. & Akira, S. Toll-like receptors as adjuvant receptors. Biochim Biophys Acta 2002, 1589(1), 1-13.
11. Krieg, A.M. The role of CpG motifs in innate immunity. Curr Opin Immunol 2000, 12(1), 35-43.
12. Martin, M., Michalek, S.M. & Katz, J. Role of innate immune factors in the adjuvant activity of monophosphoryl lipid A. Infect Immun 2003, 71(5), 2498-2507.
13. Gursel, I., Gursel, M., Ishii, K.J. & Klinman, D.M. Sterically stabilized cationic liposomes improve the uptake and immunostimulatory activity of CpG oligonucleotides. J Immunol 2001, 167(6), 3324-3328.
14. Olsen, G.J. Microbial ecology: Archaea, Archaea, everywhere. Nature 1994, 371(6499), 657-658.
15. Kates, M. Archaebacterial lipids: structure, biosynthesis and function. Biochem Soc Symp 1992, 58, 51-72.
16. Sprott, G.D. Structures of archaebacterial membrane lipids. J Bioenerg Biomembr 1992, 24(6), 555-566.
17. Kates, M., Kushwaha, S.C. & Sprott, G.D. Lipids of purple membrane from extreme halophiles and methanogenic bacteria. Methods Enzymol 1982, 88, 98-111.
18. Kates, M. Structure, physical properties, and function of archaebacterial lipids. Prog Clin Biol Res 1988, 282, 357-384.
19. Nichols, D.S., Miller, M.R., Davies, N.W., Goodchild, A., Raftery, M. & Cavicchioli, R. Cold adaptation in the Antarctic Archaeon Methanococcoides burtonii involves membrane lipid unsaturation. J Bacteriol 2004, 186(24), 8508-8515.
20. Sprott, G.D., Meloche, M. & Richards, J.C. Proportions of diether, macrocyclic diether, and tetraether lipids in Methanococcus jannaschii grown at different temperatures. J Bacteriol 1991, 173(12), 3907-3910.
21. Sprott, G.D., Agnew, B.J. & Patel, G.B. Structural features of ether lipids in the archaeobacterial thermophiles Pyrococcus furiosus, Methanopyrus kandleri, Methanothermus fervidus, and Sulfolobus acidocaldarius. Can J Microbiol 1997, 43, 467-476.
22. Sprott, G.D., Ferrante, G. & Ekiel, I. Tetraether lipids of Methanospirillum hungatei with head groups consisting of phospho-N,N-dimethylaminopentanetetrol, phospho-N,N,N-trimethylaminopentanetetrol, and carbohydrates. Biochim Biophys Acta 1994, 1214(3), 234-242.
23. Tengerdy, R.P. & Lacetera, N.G. Vitamin E adjuvant formulations in mice. Vaccine 1991, 9(3), 204-206.
24. Folkers, K., Morita, M. & McRee, J., Jr. The activities of coenzyme Q10 and vitamin B6 for immune responses. Biochem Biophys Res Commun 1993, 193(1), 88-92.
25. Cippitelli, M. & Santoni, A. Vitamin D3: a transcriptional modulator of the interferon-gamma gene. Eur J Immunol 1998, 28(10), 3017-3030.
26. Clavreul, A., D'Hellencourt, C.L., Montero-Menei, C., Potron, G. & Couez, D. Vitamin D differentially regulates B7.1 and B7.2 expression on human peripheral blood monocytes. Immunology 1998, 95(2), 272-277.
27. Lee, T.C. Biosynthesis and possible biological functions of plasmalogens. Biochim Biophys Acta 1998, 1394(2-3), 129-145.
28. Ekiel, I., Smith, I.C. & Sprott, G.D. Biosynthetic pathways in Methanospirillum hungatei as determined by 13C nuclear magnetic resonance. J Bacteriol 1983, 156(1), 316-326.
29. Ekiel, I., Sprott, G.D. & Smith, I.C. Mevalonic acid is partially synthesized from amino acids in Halobacterium cutirubrum: a 13C nuclear magnetic resonance study. J Bacteriol 1986, 166(2), 559-564.
30. Patel, G.B. & Sprott, G.D. Archaeobacterial ether lipid liposomes (archaeosomes) as novel vaccine and drug delivery systems. Crit Rev Biotechnol 1999, 19(4), 317-357.
31. New, R. Preparation of Liposomes, IRL Press, Oxford, pp. 33-104.
32. Sprott, G.D., Patel, G.B. & Krishnan, L. Archaeobacterial ether lipid liposomes as vaccine adjuvants. Methods Enzymol 2003, 373, 155-172.
33. Wessel, D. & Flugge, U.I. A method for the quantitative recovery of protein in dilute solution in the presence of detergents and lipids. Anal Biochem 1984, 138(1), 141-143.
34. Sprott, G.D., Sad, S., Fleming, L.P., Dicaire, C.J., Patel, G.B. & Krishnan, L. Archaeosomes varying in lipid composition differ in receptor-mediated endocytosis and differentially adjuvant immune responses to entrapped antigen. Archaea 2003, 1(3), 151-164.
35. Swain, M., Brisson, J.R., Sprott, G.D., Cooper, F.P. & Patel, G.B. Identifi cation of beta-l-gulose as the sugar moiety of the main polar lipid of Thermoplasma acidophilum. Biochim Biophys Acta 1997, 1345(1), 56-64.
36. Shimada, H., Nemoto, N., Shida, Y., Oshima, T. & Yamagishi, A. Complete polar lipid composition of Thermoplasma acidophilum HO-62 determined by highperformance liquid chromatography with evaporative light-scattering detection. J Bacteriol 2002, 184(2), 556-563.
37. Szebeni, J. & Toth, K. Lipid peroxidation in hemoglobin-containing liposomes: effects of membrane phospholipid composition and cholesterol content. Biochim Biophys Acta 1986, 857(2), 139-145.
38. Crommelin, D.J. & Storm, G. Liposomes: from the bench to the bed. J Liposome Res 2003, 13(1), 33-36.
39. Aramaki, Y., Tomizawa, H., Hara, T., Yachi, K., Kikuchi, H. & Tsuchiya, S. Stability of liposomes in vitro and their uptake by rat Peyer's patches following oral administration. Pharm Res 1993, 10(8), 1228-1231.
40. Gliozzi, A., Relini, A. & Chong, P.L.G. Structure and permeability properties of biomimetic membranes of bolaform archaeal tetraether lipids. J Membr Sci 2002, 206, 131-147.
41. Beveridge, T.J., Choquet, C.G., Patel, G.B. & Sprott, G.D. Freeze-fracture planes of methanogen membranes correlate with the content of tetraether lipids. J Bacteriol 1993, 175(4), 1191-1197.
42. Choquet, C.G., Patel, G.B., Beveridge, T.J. & Sprott, G.D. Stability of pressureextruded liposomes made from archaeobacterial ether lipids. Appl Microbiol Biotechnol 1994, 42(2-3), 375-384.
43. Sprott, G.D., Dicaire, C.J., Fleming, L.P. & Patel, G.B. Stability of liposomes prepared from archaeobacterial lipids and phsphatidylcholine mixtures. Cells Mater 1996, 6, 143-155.
44. Patel, G.B., Agnew, B.J., Deschatelets, L., Fleming, L.P. & Sprott, G.D. In vitro assessment of archaeosome stability for developing oral delivery systems. Int J Pharm 2000, 194(1), 39-49.
45. Grakoui, A., Bromley, S.K., Sumen, C., Davis, M.M., Shaw, A.S., Allen, P.M. et al. The immunological synapse: a molecular machine controlling T cell activation. Science 1999, 285(5425), 221-227.
46. Banchereau, J. & Steinman, R.M. Dendritic cells and the control of immunity. Nature 1998, 392(6673), 245-252.
47. Copland, M.J., Baird, M.A., Rades, T., McKenzie, J.L., Becker, B., Reck, F. et al. Liposomal delivery of antigen to human dendritic cells. Vaccine 2003, 21(9-10), 883-890.
48. Nair, S., Zhou, F., Reddy, R., Huang, L. & Rouse, B.T. Soluble proteins delivered to dendritic cells via pH-sensitive liposomes induce primary cytotoxic T lymphocyte responses in vitro. J Exp Med 1992, 175(2), 609-612.
49. Makabi-Panzu, B., Lessard, C., Beauchamp, D., Desormeaux, A., Poulin, L., Tremblay, M. et al. Uptake and binding of liposomal 2',3-dideoxycytidine by RAW 264.7 cells: a three-step process. J Acquir Immune Defi c Syndr Hum Retrovirol 1995, 8(3), 227-235.
50. Tolson, D.L., Latta, R.K., Patel, G.B. & Sprott, G.D. Uptake of archaeobacterial and conventional liposomes by phagocytic cells. J Liposome Res 1996, 6, 755-776.
51. Gurnani, K., Kennedy, J., Sad, S., Sprott, G.D. & Krishnan, L. Phosphatidylserine receptor-mediated recognition of archaeosome adjuvant promotes endocytosis and MHC class I cross-presentation of the entrapped antigen by phagosome-to-cytosol transport and classical processing. J Immunol 2004, 173(1), 566-578.
52. Sprott, G.D., Brisson, J., Dicaire, C.J., Pelletier, A.K., Deschatelets, L.A., Krishnan, L. et al. A structural comparison of the total polar lipids from the human archaea Methanobrevibacter smithii and Methanosphaera stadtmanae and its relevance to the adjuvant activities of their liposomes. Biochim Biophys Acta 1999, 1440(2-3), 275-288.
53. Somersan, S. & Bhardwaj, N. Tethering and tickling: a new role for the phosphatidylserine receptor. J Cell Biol 2001, 155(4), 501-504.
54. Krishnan, L., Sad, S., Patel, G.B. & Sprott, G.D. Archaeosomes induce long-term CD8+ cytotoxic T cell response to entrapped soluble protein by the exogenous cytosolic pathway, in the absence of CD4+ T cell help. J Immunol 2000, 165(9), 5177-5185.
55. Miller, T.L. & Wolin, M.J. Methanogens in human and animal intestinal tracts. Syst Appl Microbiol 1986, 7, 223-229.
56. Lepp, P.W., Brinig, M.M., Ouverney, C.C., Palm, K., Armitage, G.C. & Relman, D. A. Methanogenic Archaea and human periodontal disease. Proc Natl Acad Sci USA 2004, 101(16), 6176-6181.
57. Krishnan, L., Sad, S., Patel, G.B. & Sprott, G.D. The potent adjuvant activity of archaeosomes correlates to the recruitment and activation of macrophages and dendritic cells in vivo. J Immunol 2001, 166(3), 1885-1893.
58. Krishnan, L., Dicaire, C.J., Patel, G.B. & Sprott, G.D. Archaeosome vaccine adjuvants induce strong humoral, cell-mediated, and memory responses: comparison to conventional liposomes and alum. Infect Immun 2000, 68(1), 54-63.
59. Krishnan, L., Sad, S., Patel, G.B. & Sprott, G.D. Archaeosomes induce enhanced cytotoxic T lymphocyte responses to entrapped soluble protein in the absence of interleukin 12 and protect against tumor challenge. Cancer Res 2003, 63(10), 2526-2534.
60. Sprott, G.D., Tolson, D.L. & Patel, G.B. Archaeosomes as novel antigen delivery systems. FEMS Microbiol Lett 1997, 154(1), 17-22.
61. Abraham, E. & Shah, S. Intranasal immunization with liposomes containing IL-2 enhances bacterial polysaccharide antigen-specifi c pulmonary secretory antibody response. J Immunol 1992, 149(11), 3719-3726.
62. Gregoriadis, G. Liposomes as immunological adjuvants: approaches to immunopotentiation including ligand-mediated targeting to macrophages. Res Immunol 1992, 143(2), 178-185.
63. Krishnan, L. & Mosmann, T.R. Functional subpopulations of CD4+ T lymphocytes. In T Lymphocyte Subpopulations in Immunotoxicology, Kimber, I. & Selgrade, M.K., Eds., Wiley, Chichester, West Sussey, England, pp. 7-32.
64. Brewer, J.M., Conacher, M., Hunter, C.A., Mohrs, M., Brombacher, F. & Alexander, J. Aluminium hydroxide adjuvant initiates strong antigen-specifi c Th2 responses in the absence of IL-4- or IL-13-mediated signaling. J Immunol 1999, 163(12), 6448-6454.
65. Gupta, R.K., Rost, B.E., Reyveld, R.E. & Siber, G.S. Adjuvant properties of aluminum and calcium compounds. In Vaccine Design, Powell, M.F. & Newman, M.J., Eds., Plenum Press, New York, 1995, pp. 229-248.
66. Sad, S. & Krishnan, L. Maintenance and attrition of T-cell memory. Crit Rev Immunol 2003, 23(1-2), 129-147.
67. Pamer, E. & Cresswell, P. Mechanisms of MHC class I-restricted antigen processing. Annu Rev Immunol 1998, 16, 323-358.
68. den Haan, J.M. & Bevan, M.J. Antigen presentation to CD8+ T cells: cross-priming in infectious diseases. Curr Opin Immunol 2001, 13(4), 437-441.
69. Zinkernagel, R.M. On cross-priming of MHC class I-specifi c CTL: rule or exception? Eur J Immunol 2002, 32(9), 2385-2392.
70. Conlan, J.W., Krishnan, L., Willick, G.E., Patel, G.B. & Sprott, G.D. Immunization of mice with lipopeptide antigens encapsulated in novel liposomes prepared from the polar lipids of various archaeobacteria elicits rapid and prolonged specifi c protective immunity against infection with the facultative intracellular pathogen, Listeria monocytogenes. Vaccine 2001, 19(25-26), 3509-3517.
71. Krishnan, L. & Sprott, G.D. Archaeosomes as self-adjuvanting delivery systems for cancer vaccines. J Drug Target 2003, 11(8-10), 515-524.
72. Shen, H., Slifka, M.K., Matloubian, M., Jensen, E.R., Ahmed, R. & Miller, J.F. Recombinant Listeria monocytogenes as a live vaccine vehicle for the induction of protective anti-viral cell-mediated immunity. Proc Natl Acad Sci USA 1995, 92(9), 3987-3991.
73. Rosenberg, S.A., Yang, J.C., Schwartzentruber, D.J., Hwu, P., Marincola, F.M., Topalian, S.L. et al. Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma. Nat Med 1998, 4(3), 321-327.
74. Toes, R.E., Blom, R.J., Offringa, R., Kast, W.M. & Melief, C.J. Enhanced tumor outgrowth after peptide vaccination: functional deletion of tumor-specifi c CTL induced by peptide vaccination can lead to the inability to reject tumors. J Immunol 1996, 156(10), 3911-3918.
75. Cheers, C., McKenzie, I.F., Pavlov, H., Waid, C. & York, J. Resistance and susceptibility of mice to bacterial infection: course of listeriosis in resistant or susceptible mice. Infect Immun 1978, 19(3), 763-770.
76. Edelson, B.T. & Unanue, E.R. Immunity to Listeria infection. Curr Opin Immunol 2000, 12(4), 425-431.
77. Pamer, E.G., Harty, J.T. & Bevan, M.J. Precise prediction of a dominant class I MHC-restricted epitope of Listeria monocytogenes. Nature 1991, 353(6347), 852-855.
78. Lipford, G.B., Wagner, H. & Heeg, K. Vaccination with immunodominant peptides encapsulated in Quil A-containing liposomes induces peptide-specifi c primary CD8+ cytotoxic T cells. Vaccine 1994, 12(1), 73-80.
79. Ballard, J.D., Collier, R.J. & Starnbach, M.N. Anthrax toxin-mediated delivery of a cytotoxic T-cell epitope in vivo. Proc Natl Acad Sci USA 1996, 93(22), 12531-12534.
80. Hess, J., Gentschev, I., Miko, D., Welzel, M., Ladel, C., Goebel, W. et al. Superior effi cacy of secreted over somatic antigen display in recombinant Salmonella vaccine induced protection against listeriosis. Proc Natl Acad Sci USA 1996, 93(4), 1458-1463.
81. Tsunoda, I., Sette, A., Fujinami, R.S., Oseroff, C., Ruppert, J., Dahlberg, C. et al. Lipopeptide particles as the immunologically active component of CTL inducing vaccines. Vaccine 1999, 17(7-8), 675-685.
82. Loing, E., Andrieu, M., Thiam, K., Schorner, D., Wiesmuller, K.H., Hosmalin, A. et al. Extension of HLA-A*0201-restricted minimal epitope by N epsilon- palmitoyllysine increases the life span of functional presentation to cytotoxic T cells. J Immunol 2000, 164(2), 900-907.
83. Freisleben, H.J., Bormann, J., Litzinger, D.C., Lehr, F., Rudolph, P., Schatton, W. et al. Toxicity and biodistribution of liposomes of the main phospholipid from the archaeobacterium Thermoplasma acidophilum. J Liposome Res 1995, 5, 215-223.
84. Omri, A., Agnew, B.J. & Patel, G.B. Short-term repeated-dose toxicity profi le of archaeosomes administered to mice via intravenous and oral routes. Int J Toxicol 2003, 22(1), 9-23.
85. Patel, G.B., Omri, A., Deschatelets, L. & Sprott, G.D. Safety of archaeosome adjuvants evaluated in a mouse model. J Liposome Res 2002, 12(4), 353-372.
86. Aderem, A. & Ulevitch, R.J. Toll-like receptors in the induction of the innate immune response. Nature 2000, 406(6797), 782-787.
87. Gordon, S. Pattern recognition receptors: doubling up for the innate immune response. Cell 2002, 111(7), 927-930.
88. Visintin, A., Mazzoni, A., Spitzer, J.H., Wyllie, D.H., Dower, S.K. & Segal, D.M. Regulation of Toll-like receptors in human monocytes and dendritic cells. J Immunol 2001, 166(1), 249-255.
89. Li, M.O., Sarkisian, M.R., Mehal, W.Z., Rakic, P. & Flavell, R.A. Phosphatidylserine receptor is required for clearance of apoptotic cells. Science 2003, 302(5650), 1560-1563.